Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenues for the second quarter of 2025.
- On a reported basis, second-quarter earnings were $0.46 per share, compared to $0.45 in the same period a year ago
- Adjusted earnings per share from continuing operations dropped to $1.18 from $1.22 a year earlier
- Second-quarter revenue increased to about $720 million from $692 million in the prior-year quarter
- Life Sciences revenues increased 5% annually to $366 million in the second quarter; Diagnostics revenue rose 3% to $354 million
- Operating income from continuing operations, on a reported basis, was $91 million, vs. $86 million in Q2 FY24
- For the full year 2025, the company raised its full-year revenue guidance to $2.84-$2.88 billion to reflect recent changes in foreign currency exchange rates; it assumes 2% to 4% organic growth
- The management also updated its adjusted earnings per share guidance to a range of $4.85 to $4.95
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%
Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues
AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat
Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts' expectations. Adjusted
Lamb Weston (LW) is set to report Q2 2026 earnings next week, here’s what to look for
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) rose over 1% on Thursday. The stock has gained 4% over the past three months. The French fry giant is slated to
